TrialThe Prostate2023

A correlative biomarker study and integrative prognostic model in chemotherapy-naïve metastatic castration-resistant prostate cancer treated with enzalutamide.

María P Fernandez-Perez et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.